Perspectives on the Future of mCRPC | Targeted Oncology - Immunotherapy . . . Ultimately, the goal for future mCRPC treatment is to provide durable and effective control of the disease, enabling patients to live longer with a better quality of life Rational combinations of these new agents could allow for longer treatment breaks and less time spent in medical settings
New Drugs for Targeted Radionuclide Therapy in Metastatic Prostate . . . Our mini review summarizes research on targeted radioactive drugs for treatment of metastatic prostate cancer Several promising radioactive pharmaceuticals are being evaluated in clinical trials, but more studies are necessary before these can be used in routine clinical practice
mCRPC Treatment - UroToday In this editorial, I cover recent therapeutic approvals in mCRPC, clinical trials, and investigational therapies
The Contemporary Treatment Landscape of mCRPC - Urology Times Can you briefly discuss the contemporary treatment landscape of mCRPC? What are the unmet needs for the treatment of mCRPC? Eg, access to agents Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs
HLD-0915 Receives FDA Fast Track Designation for mCRPC Treatment HLD-0915, a novel therapy for mCRPC, received FDA fast track designation to expedite its development and review process The drug uses a unique "hold and kill" mechanism, forming a ternary complex to target prostate cancer cells